Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Effectiveness of Open-Label Clobazam in Subjects with Lennox-Gastaut Syndrome
2007-004350-82Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clobazam in Lennox-Gastaut syndrome (LGS), sponsored by Lundbeck. Primary endpoint: Percent reduction in drop seizures over time. Started Jan 2008; status: completed.
02
Drugs
clobazam
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on 2007-004350-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004350-82.